While persistent daily use of rtCGM is considered essential for intensive insulin management,1–3,9–14 clinical trials and recent meta-analyses have reported the value of rtCGM use in individuals with T2D independent of their treatment regimen.15–18 The real-world data included in this report add to the growing body of evidence indicating that intermittent rtCGM use with less intensive treatment regimens is associated with significant glycemic improvements,19–21 creates valuable teaching opportunities,22 and is effective in promoting desired self-care behaviors.20 Here, INS is linked to type 2 diabetes mellitus.